Evidence map›Paper›PMID 36118740›Full record

ReviewFrontiers in nutrition2022

The current research status and strategies employed to modify food-derived bioactive peptides.

Julieth Joram Majura, Wenhong Cao, Zhongqin Chen, Kyi Kyi Htwe, Wan Li, Ran Du, Pei Zhang, Huina Zheng, Jialong Gao

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Synergistic Anti-Foods (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Review
  10. Article
  11. Comparative assessment ofFrontiers in nutrition · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Julieth Joram MajuraCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang, China.
Wenhong CaoCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang, China.
Zhongqin ChenCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang, China.
Kyi Kyi HtweCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang, China.
Wan LiCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang, China.
Ran DuCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang, China.
Pei ZhangCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang, China.
Huina ZhengCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang, China.
Jialong GaoCollege of Food Science and Technology, Guangdong Ocean University, Zhanjiang, China.
Guangdong Ocean University · CNKey Laboratory of Guangdong Province · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The ability of bioactive peptides to exert biological functions has mainly contributed to their exploitation. The exploitation and utilization of these peptides have grown tremendously over the past two decades. Food-derived peptides from sources such as plant, animal, and marine proteins and their byproducts constitute a more significant portion of the naturally-occurring peptides that have been documented. Due to their high specificity and biocompatibility, these peptides serve as a suitable alternative to pharmacological drugs for treating non-communicable diseases (such as cardiovascular diseases, obesity, and cancer). They are helpful as food preservatives, ingredients in functional foods, and dietary supplements in the food sector. Despite their unique features, the application of these peptides in the clinical and food sector is to some extent hindered by their inherent drawbacks such as toxicity, bitterness, instability, and susceptibility to enzymatic degradation in the gastrointestinal tract. Several strategies have been employed to eliminate or reduce the disadvantages of peptides, thus enhancing the peptide bioactivity and broadening the opportunities for their applications. This review article focuses on the current research status of various bioactive peptides and the strategies that have been implemented to overcome their disadvantages. It will also highlight future perspectives regarding the possible improvements to be made for the development of bioactive peptides with practical uses and their commercialization.

Indexed as

bioactivityfood-derived bioactive peptidesfunctional foodsinherent drawbacksmodificationtherapeutic drugs

Identifiers

PMID36118740
PMCPMC9479208
OpenAlexW4294243466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.